January 7, 2010 – 12:57 pm
Many of my backstories have featured Pain Researchers. In several, I have featured use of our our i-Fect ™ Transfection Kit for enhancing the delivery of siRNA in vitro and in vivo to study the expression of genes invovled in Neuropathic and Nociceptive Pain.
I am excited to present a recent publication that includes use of this kit [...]
April 20, 2009 – 10:54 am
I have featured successes with delivering siRNA in vivo in this blog. These included stories on Dr. Philipe Serrat and his team at the University of Sherbrooke and Dr. Mark Behlke’s work at Integrated DNA and Dicerna.
I am pleased to report the parade of success with use our i-FectTM in vivo grows.
Here’s the most recent study:
Christian Ndong, [...]
By Pete Shuster
|
Posted in Pain Research, i-Fect Transfection Kits, siRNA
|
Also tagged Add new tag, Dr. Jennifer Laird, Gene Silencing, in vivo RNAi, Inflammatory Pain, intrathecal delivery of siRNA, IT Delivery of siRNA, rat sensory neuron-specific receptor, snsr1, TRPV1
|
October 19, 2008 – 2:06 pm
Researchers using siRNA complexed with our i-Fect ™ transfection regent have successfully knocked down ASIC3 Receptors in vivo. This publication joins the growing parade (starting with Luo et al, 2005) that reference successful modulation of receptors involved in pain using siRNA complexes. These studies all share animal behavior studies showing a marked change in response to pain [...]
September 29, 2008 – 1:05 pm
Shedding Light on New Pain Pathways
There is no joy in Painville. Our answer to pain is: “make it go away”! It spoils quality of life. The socio-economic costs for treatments, loss of productivity and absenteeism, are measured in billions USD$.
Today, moderate to severe pain is treated mostly with NSAIDs, narcotics or tricyclics (anti-depressants). Properly prescribed, [...]
By Pete Shuster
|
Posted in DsiRNA, Pain Research, People, featured researchers
|
Also tagged APJ, CCR2, Chronic Pain, Dr. Philippe Sarret, morphine, Neurotensin Receptors, Nociceptive Pain, non-Narcotics, non-Opioid Pain Pathway, NTS2, Opioid Receptors, opioidergic-independent pathways, Pain Pathways, Pain Therapies, University of Sherbrooke
|